Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage.

52W Range

19thpctl

Volume

0.99×avg

Market Cap

216.64MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Tonix Pharmaceuticals Holding Corp.

TNXPNASDAQ Capital Market·USD·Closed

Tonix Pharmaceuticals Holding Corp.

TNXPNASDAQ·USD·Closed

$13.59

+0.22%

$13.59

+$0.03 (0.22%)

52W Range

19thpctl

Volume

0.99×avg

Mkt Cap

216.64MUSD

P/E

-1.0TTM

Div Yield

–ann

TNXP: Tonix Pharmaceuticals Holding Corp. Stock Analysis | finqOS